Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SODIUM EDECRIN DIN 00268313

Status: Dormant
Holder: BAUSCH HEALTH, CANADA INC.
Molecule: ETHACRYNIC ACID (ETHACRYNATE SODIUM)
Available to quote

Health Canada record

Active ingredient(s)ETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MG
Dosage formPowder For Solution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCC03CC01 ETACRYNIC ACID
Original market date31-Dec-1968
Current status date22-Dec-2020
SourceHealth Canada DPD

Establishment licence of the holder

Bausch Health Companies Inc. — licence 101880, currently licensed, last inspection rating C (2026-06-01).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ETHACRYNIC ACID (ETHACRYNATE SODIUM)

DINProductCompanyFormStrengthStatus
02462362ETHACRYNATE SODIUMSTERIMAX INCPowder For SolutionETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MGMarketed
02479591ETHACRYNATE SODIUM FOR INJECTIONENDO PAR INNOVATION COMPANY, LLCPowder For SolutionETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MGCancelled Pre Market
02469456ETHACRYNATE SODIUM FOR INJECTION USPSTERIMAX INCPowder For SolutionETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MGDormant

Notices of Compliance

NOCDateSubmissionReason
248712020-12-22New Drug Submission (NDS)CHANGE IN PRODUCT OWNERSHIP
131432012-03-26New Drug Submission (NDS)Manufacturer name change
91312007-07-25New Drug Submission (NDS)MANUFACTURER NAME CHANGE
Request a quote for SODIUM EDECRIN

How to read a Canadian DIN record